Home - Products - Others - Other Targets - N-Benzoyl-(2R,3S)-3-phenylisoserine

N-Benzoyl-(2R,3S)-3-phenylisoserine

CAS No. 132201-33-3

N-Benzoyl-(2R,3S)-3-phenylisoserine ( —— )

Catalog No. M17948 CAS No. 132201-33-3

(2R, 3S)-N-Benzoyl-3-phenylisoserine is an intermediate in the preparation of potent anticancer drug Paclitaxel used to study the location of the binding sites.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 56 In Stock
50MG 82 In Stock
100MG 120 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-Benzoyl-(2R,3S)-3-phenylisoserine
  • Note
    Research use only, not for human use.
  • Brief Description
    (2R, 3S)-N-Benzoyl-3-phenylisoserine is an intermediate in the preparation of potent anticancer drug Paclitaxel used to study the location of the binding sites.
  • Description
    (2R, 3S)-N-Benzoyl-3-phenylisoserine is an intermediate in the preparation of potent anticancer drug Paclitaxel used to study the location of the binding sites. It shows cytotoxic, antiviral and immunomodulatory activity.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132201-33-3
  • Formula Weight
    285.29
  • Molecular Formula
    C16H15NO4
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    O[C@H]([C@@H](NC(=O)c1ccccc1)c1ccccc1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Paal K, et al. Paclitaxel binding to human serum albumin--automated docking studies[J]. Bioorganic & Medicinal Chemistry, 2007, 15(3):1323-1329.
molnova catalog
related products
  • Haloxyfop methyl est...

    Methyl 2-(4-((3-chloro-5-(trifluoromethyl)-2-pyridinyl)oxy)phenoxy)propanoate is a selective herbicide, an inhibitor of fatty acid synthesis, and has a systemic effect.

  • HCV-IN-30

    HCV-IN-30 is an HCV NS5A replication complex inhibitor (IC50s: 901 and 102 nM for genotypes 1a and 1b replicons).

  • 1-Hydroxy-2-naphthoi...

    Metabolite from phenanthrene degradation.